| Primary |
| Diabetes Mellitus |
56.7% |
| Type 2 Diabetes Mellitus |
15.7% |
| Drug Use For Unknown Indication |
15.0% |
| Product Used For Unknown Indication |
4.1% |
| Hypertension |
1.3% |
| Non-small Cell Lung Cancer |
1.3% |
| Diabetes Mellitus Non-insulin-dependent |
0.9% |
| Arthritis |
0.6% |
| Eye Infection |
0.6% |
| Psoriasis |
0.6% |
| Agitation |
0.3% |
| Blood Cholesterol Increased |
0.3% |
| Blood Glucose |
0.3% |
| Bronchitis |
0.3% |
| Convulsion |
0.3% |
| Depression |
0.3% |
| Glaucoma |
0.3% |
| Hypothyroidism |
0.3% |
| Left Ventricular Dysfunction |
0.3% |
| Peripheral Arterial Occlusive Disease |
0.3% |
|
| Myocardial Infarction |
17.3% |
| Weight Increased |
13.4% |
| Cerebrovascular Accident |
7.8% |
| Cardiac Failure Congestive |
7.1% |
| Hypoglycaemia |
6.0% |
| Vision Blurred |
5.7% |
| Death |
5.3% |
| Drug Ineffective |
4.2% |
| Blood Glucose Increased |
3.9% |
| Coronary Artery Disease |
3.9% |
| Tremor |
3.5% |
| Myocardial Ischaemia |
3.2% |
| Dizziness |
2.8% |
| Oedema Peripheral |
2.8% |
| Swelling |
2.8% |
| Cardiovascular Disorder |
2.1% |
| Nausea |
2.1% |
| Stent Placement |
2.1% |
| Vomiting |
2.1% |
| Fatigue |
1.8% |
|
| Secondary |
| Diabetes Mellitus |
61.0% |
| Drug Use For Unknown Indication |
22.1% |
| Type 2 Diabetes Mellitus |
13.2% |
| Product Used For Unknown Indication |
1.6% |
| Diabetes Mellitus Non-insulin-dependent |
0.6% |
| Type 1 Diabetes Mellitus |
0.2% |
| Blood Aldosterone Increased |
0.1% |
| Chronic Obstructive Pulmonary Disease |
0.1% |
| Hypertension |
0.1% |
| Joint Injury |
0.1% |
| Micturition Disorder |
0.1% |
| Pain |
0.1% |
| Sarcoidosis |
0.1% |
| Sinusitis |
0.1% |
| Diabetes Mellitus Insulin-dependent |
0.1% |
| Hypothyroidism |
0.1% |
| Microalbuminuria |
0.1% |
| Non-small Cell Lung Cancer |
0.1% |
| Throat Irritation |
0.1% |
|
| Myocardial Infarction |
43.1% |
| Myocardial Ischaemia |
9.9% |
| Cardiac Failure Congestive |
6.8% |
| Cerebrovascular Accident |
6.1% |
| Coronary Artery Disease |
5.0% |
| Transient Ischaemic Attack |
4.0% |
| Weight Increased |
3.0% |
| Cardiovascular Disorder |
2.2% |
| Pneumonia |
2.2% |
| Cardiac Disorder |
2.1% |
| Stent Placement |
2.1% |
| Pain |
1.9% |
| Heart Injury |
1.8% |
| Death |
1.7% |
| Ventricular Fibrillation |
1.7% |
| Renal Failure |
1.6% |
| Pulmonary Congestion |
1.3% |
| Acute Myocardial Infarction |
1.2% |
| Thrombosis |
1.2% |
| Chest Pain |
1.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.5% |
| Drug Use For Unknown Indication |
20.6% |
| Diabetes Mellitus Non-insulin-dependent |
12.4% |
| Diabetes Mellitus |
8.7% |
| Type 2 Diabetes Mellitus |
5.8% |
| Hypertension |
5.0% |
| Blood Cholesterol Increased |
4.8% |
| Crohn's Disease |
4.5% |
| Depression |
2.9% |
| High Density Lipoprotein Decreased |
1.6% |
| Pancreatic Carcinoma Metastatic |
1.6% |
| Smoking Cessation Therapy |
1.6% |
| Erectile Dysfunction |
1.3% |
| Adenocarcinoma Pancreas |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
| Idiopathic Pulmonary Fibrosis |
1.1% |
| Pain |
1.1% |
| Bipolar Disorder |
0.8% |
| Colitis Ulcerative |
0.8% |
| Dyspepsia |
0.8% |
|
| Weight Decreased |
27.8% |
| Nausea |
12.4% |
| Vomiting |
7.2% |
| Tremor |
5.2% |
| Weight Increased |
5.2% |
| Insomnia |
4.1% |
| Blood Glucose Increased |
3.1% |
| Dizziness |
3.1% |
| Feeling Hot |
3.1% |
| Pruritus |
3.1% |
| Sensory Loss |
3.1% |
| Stomach Discomfort |
3.1% |
| Surgery |
3.1% |
| Unevaluable Event |
3.1% |
| Urticaria |
3.1% |
| Abdominal Hernia |
2.1% |
| Diarrhoea |
2.1% |
| Diverticular Perforation |
2.1% |
| Drug Ineffective |
2.1% |
| Fatigue |
2.1% |
|
| Interacting |
| Blood Cholesterol |
33.3% |
| Diabetes Mellitus |
33.3% |
| Fibromyalgia |
33.3% |
|
|
